A1 Refereed original research article in a scientific journal
Suppression of TGF beta and Angiogenesis by Type VII Collagen in Cutaneous SCC
Authors: Martins VL, Caley MP, Moore K, Szentpetery Z, Marsh ST, Murrell DF, Kim MH, Avari M, McGrath JA, Cerio R, Kivisaari A, Kahari VM, Hodivala-Dilke K, Brennan CH, Chen M, Marshall JF, O'Toole EA
Publisher: OXFORD UNIV PRESS INC
Publication year: 2016
Journal: JNCI: Journal of the National Cancer Institute
Journal name in source: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE
Journal acronym: JNCI-J NATL CANCER I
Article number: ARTN djv293
Volume: 108
Issue: 1
Number of pages: 11
ISSN: 0027-8874
DOI: https://doi.org/10.1093/jnci/djv293
Conclusions: Type VII collagen suppresses TGF beta signaling and angiogenesis in cutaneous SCC. Patients with RDEB SCC may benefit from anti-angiogenic therapy.